• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产尿石素的人体肠道细菌戈登氏尿石杆菌和异尿石素埃拉格杆菌对不同膳食酚类化合物的代谢。

Metabolism of different dietary phenolic compounds by the urolithin-producing human-gut bacteria Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens.

作者信息

García-Villalba Rocío, Beltrán David, Frutos María D, Selma María V, Espín Juan C, Tomás-Barberán Francisco A

机构信息

Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC, P.O. Box 164, 30100 Campus de Espinardo, Murcia, Spain.

出版信息

Food Funct. 2020 Aug 1;11(8):7012-7022. doi: 10.1039/d0fo01649g. Epub 2020 Jul 27.

DOI:10.1039/d0fo01649g
PMID:32716447
Abstract

Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens are two human gut bacterial species that convert ellagic acid into urolithins. Urolithins are bioactive postbiotics produced by dehydroxylation reactions catalyzed by different catechol-dehydroxylases. The metabolic ability of these anaerobic bacteria on other dietary-phenolic compounds is unknown. In the present study, we evaluated the metabolism of flavonoids (quercetin, hesperetin, hesperidin, nobiletin, catechin, isoxanthohumol), isoflavonoids (daidzein), coumarins (esculetin, umbelliferone, scoparone), phenylpropanoids [caffeic acid; 3-(3',4'-dihydroxyphenyl)propanoic acid (dihydrocaffeic acid); rosmarinic acid, and chlorogenic acid], benzoic acid derivatives (gallic acid, ellagic acid), lignans (secoisolariciresinol diglucoside), stilbenes (resveratrol), and secoiridoids (oleuropein) by G. urolithinfaciens DSM 27213 and E. isourolithinifaciens DSM 104140. Both strains metabolized ellagic acid leading to the characteristic urolithins. They also metabolized caffeic, dihydrocaffeic, rosmarinic, and chlorogenic acids. The rest of the phenolic compounds were not transformed. Catechol dehydroxylation and double bond reduction were prominent transformations observed during the incubations. The enzymatic activities seem to have a narrow substrate scope as many catechol- (quercetin, catechin, esculetin, gallic acid) and double bond-containing (resveratrol, esculetin, scoparone, umbelliferone) phenolics were not metabolized. The catechol-dehydroxylase activity was more efficient in E. isourolithinifaciens, while the reductase activity was more relevant in G. urolithinfaciens.

摘要

尿石素生成戈登氏菌和异尿石素生成埃拉格氏菌是两种可将鞣花酸转化为尿石素的人体肠道细菌。尿石素是由不同儿茶酚脱羟基酶催化的脱羟基反应产生的具有生物活性的后生元。这些厌氧菌对其他膳食酚类化合物的代谢能力尚不清楚。在本研究中,我们评估了尿石素生成戈登氏菌DSM 27213和异尿石素生成埃拉格氏菌DSM 104140对黄酮类化合物(槲皮素、橙皮素、橙皮苷、川陈皮素、儿茶素、异黄腐酚)、异黄酮类化合物(大豆苷元)、香豆素类化合物(七叶亭、伞形花内酯、滨蒿内酯)、苯丙烷类化合物[咖啡酸;3-(3',4'-二羟基苯基)丙酸(二氢咖啡酸);迷迭香酸和绿原酸]、苯甲酸衍生物(没食子酸、鞣花酸)、木脂素类化合物(开环异落叶松脂素二葡萄糖苷)、芪类化合物(白藜芦醇)和裂环环烯醚萜类化合物(橄榄苦苷)的代谢情况。两种菌株都能代谢鞣花酸,生成特征性的尿石素。它们还能代谢咖啡酸、二氢咖啡酸、迷迭香酸和绿原酸。其余的酚类化合物未被转化。在培养过程中观察到儿茶酚脱羟基和双键还原是主要的转化反应。酶活性的底物范围似乎较窄,因为许多含儿茶酚的(槲皮素、儿茶素、七叶亭、没食子酸)和含双键的(白藜芦醇、七叶亭、滨蒿内酯、伞形花内酯)酚类化合物未被代谢。异尿石素生成埃拉格氏菌中的儿茶酚脱羟基酶活性更高,而尿石素生成戈登氏菌中的还原酶活性更显著。

相似文献

1
Metabolism of different dietary phenolic compounds by the urolithin-producing human-gut bacteria Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens.产尿石素的人体肠道细菌戈登氏尿石杆菌和异尿石素埃拉格杆菌对不同膳食酚类化合物的代谢。
Food Funct. 2020 Aug 1;11(8):7012-7022. doi: 10.1039/d0fo01649g. Epub 2020 Jul 27.
2
Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species.两种人体肠道戈登氏菌将鞣花酸转化为尿石素能力的描述
Food Funct. 2014 Aug;5(8):1779-84. doi: 10.1039/c4fo00092g.
3
Evaluation of electron-transferring cofactor mediating enzyme systems involved in urolithin dehydroxylation in Gordonibacter urolithinfaciens DSM 27213.评价戈登氏菌 DSM 27213 中参与尿石素脱氢的电子传递辅助因子介导的酶系统。
J Biosci Bioeng. 2020 May;129(5):552-557. doi: 10.1016/j.jbiosc.2019.11.014. Epub 2020 Jan 23.
4
Oral supplementation of Gordonibacter urolithinfaciens promotes ellagic acid metabolism and urolithin bioavailability in mice.口服补充戈登氏菌(Gordonibacter urolithinfaciens)可促进小鼠体内鞣花酸代谢和鞣花酸生物利用度。
Food Chem. 2024 Mar 30;437(Pt 2):137953. doi: 10.1016/j.foodchem.2023.137953. Epub 2023 Nov 7.
5
The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism.与超重和肥胖相关的人体肠道微生物生态决定了鞣花酸的代谢。
Food Funct. 2016 Apr;7(4):1769-74. doi: 10.1039/c5fo01100k.
6
Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut.戈登氏尿道石菌,一种从人类肠道中分离出的能够产生尿石素的细菌。
Int J Syst Evol Microbiol. 2014 Jul;64(Pt 7):2346-2352. doi: 10.1099/ijs.0.055095-0. Epub 2014 Apr 17.
7
Complete Genome Sequence of the New Urolithin-Producing Bacterium DSM 27213.新型产尿石素细菌DSM 27213的全基因组序列
Genome Announc. 2017 Dec 14;5(50):e01120-17. doi: 10.1128/genomeA.01120-17.
8
Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation.鞣花酸与肠道微生物群代谢产物尿石素A:关于其来源、代谢分布、健康益处及生物转化的综述
Crit Rev Food Sci Nutr. 2023;63(24):6900-6922. doi: 10.1080/10408398.2022.2036693. Epub 2022 Feb 10.
9
Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid.从鞣花酸中分离出能够产生生物活性代谢物异尿石素A的人肠道细菌。
Front Microbiol. 2017 Aug 7;8:1521. doi: 10.3389/fmicb.2017.01521. eCollection 2017.
10
Gut Bacteria Involved in Ellagic Acid Metabolism To Yield Human Urolithin Metabotypes Revealed.揭示了参与鞣花酸代谢生成人类尿石素代谢型的肠道细菌。
J Agric Food Chem. 2023 Mar 8;71(9):4029-4035. doi: 10.1021/acs.jafc.2c08889. Epub 2023 Feb 25.

引用本文的文献

1
Urolithin as a Metabolite of Ellagitannins and Ellagic Acid from Fruits and Nuts Produced by the Gut Microbiota: Its Role on Non-Communicable Diseases.尿石素作为肠道微生物群产生的水果和坚果中鞣花单宁和鞣花酸的代谢产物:其在非传染性疾病中的作用。
Curr Nutr Rep. 2025 Apr 3;14(1):55. doi: 10.1007/s13668-025-00645-0.
2
Causal associations between gut microbiota and type 2 diabetes mellitus subtypes: a mendelian randomization analysis.肠道微生物群与2型糖尿病亚型之间的因果关联:孟德尔随机化分析
BMC Endocr Disord. 2025 Mar 24;25(1):79. doi: 10.1186/s12902-025-01863-x.
3
Diet-derived urolithin A is produced by a dehydroxylase encoded by human gut Enterocloster species.
饮食来源的尿石素A由人类肠道埃氏菌属编码的一种脱羟基酶产生。
Nat Commun. 2025 Jan 24;16(1):999. doi: 10.1038/s41467-025-56266-2.
4
Phenolic Compounds and Anthocyanins in Legumes and Their Impact on Inflammation, Oxidative Stress, and Metabolism: Comprehensive Review.豆类中的酚类化合物和花青素及其对炎症、氧化应激和代谢的影响:综述
Molecules. 2025 Jan 4;30(1):174. doi: 10.3390/molecules30010174.
5
Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study.通过饮用康普茶调节人类肠道微生物群和健康指标:一项对照临床研究。
Sci Rep. 2024 Dec 30;14(1):31647. doi: 10.1038/s41598-024-80281-w.
6
The Gut-Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction.肠-心轴:分子视角与心肌梗死的意义。
Int J Mol Sci. 2024 Nov 20;25(22):12465. doi: 10.3390/ijms252212465.
7
Perspective on the Coevolutionary Role of Host and Gut Microbiota in Polyphenol Health Effects: Metabotypes and Precision Health.多酚健康效应中宿主与肠道微生物群共进化作用的研究视角:代谢类型与精准健康
Mol Nutr Food Res. 2024 Nov;68(22):e2400526. doi: 10.1002/mnfr.202400526. Epub 2024 Nov 13.
8
Metatranscriptomics-guided discovery and characterization of a polyphenol-metabolizing gut microbial enzyme.基于宏转录组学的多酚代谢肠道微生物酶的发现和特性研究。
Cell Host Microbe. 2024 Nov 13;32(11):1887-1896.e8. doi: 10.1016/j.chom.2024.10.002. Epub 2024 Oct 28.
9
Depressive Symptoms and Gut Microbiota after Bowel Preparation and Colonoscopy: A Pre-Post Intervention Study.肠道准备和结肠镜检查后的抑郁症状与肠道微生物群:一项干预前后研究
Microorganisms. 2024 Sep 27;12(10):1960. doi: 10.3390/microorganisms12101960.
10
Gordonibacter faecis sp. nov., producing urolithin C from ellagic acid, isolated from feces of healthy Korean subjects.戈登氏菌属粪产亚种,从健康韩国受试者粪便中分离得到,能够从鞣花酸生成尿石素 C。
Arch Microbiol. 2024 Feb 18;206(3):108. doi: 10.1007/s00203-024-03844-5.